CompletedNot Applicable

Optimizing Left Ventricular Lead To Improve Cardiac Output

United States12 participantsStarted 2010-12

Plain-language summary

The purpose of this study is to determine if optimal lead placement, guided by the largest improvement in aortic flow measured by Doppler will: 1. Improve the way the heart's left ventricle functions 2. Decrease the number of hospital admissions for heart failure related symptoms 3. Reduces uncoordinated heart contractions 4. Improve quality of life as measured by the Minnesota Living with Heart Failure Questionaire and NYHA Class assessed after six months

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinical indication for CRT-P or CRT-D * QRS Duration\>=120 MSEC * Left Ventricular Ejection fraction\<=35% * NYHA Class III-IV * History of Cardiomyopathy, least one month post MI, or at least six months old in case of non-ischemic cardiomyopathy * At least 18 years of afe Exclusion Criteria: * Previous implanted CRT-P/CRT-D * woman who are pregnant * Psychological or emotional problems

What they're measuring

Change in Left Ventricular End Systolic Volume (LVESV) using the difference from baseline to six months

Timeframe: Six months

Trial details

NCT IDNCT01399801

SponsorAnn Marie Chikowski

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-09-25

View on ClinicalTrials.gov More Ischemic Congestive Cardiomyopathy trials